James W. Newman Jr.

ADIL

James W. Newman Jr. serves as Director at Adial Pharmaceuticals, Inc. (ADIL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$95.8K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$95.8K

Companies Traded

ADIL

Active Period

Nov 2021 – Dec 2021

2 total trades

Most Recent

Buy ADIL

Dec 30, 2021 · $67.3K

James W. Newman Jr.'s Insider Trading at Adial Pharmaceuticals, Inc. (ADIL)

Buys

2 · $95.8K

Sells

0 · $0.00

Total Shares Bought

35,000

Total Shares Sold

ADIL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 30, 2021	Buy	25,000	$2.69	$67.3K	0
Nov 26, 2021	Buy	10,000	$2.85	$28.5K	0

Related Insiders

Coastlands Capital LP

10 percent owner

ADILBuy · Jul 13, 2026

Explore More Insider Trading Data

ADIL Insider Trading Activity

View all insider trades at Adial Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity